Merus N.V.
MRUSDelisted Dec 30, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651311
Merus N.V. was delisted on Dec 30, 2025; its insiders filed their last Form 4 on Dec 30, 2025; 268 institutions reported holding it in 13F filings for Q3 2025, worth $6.70B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2022
Institutional positions in Merus N.V. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 100
- +7 vs. Q2 2022
- Shares held
- 34.3M
- −727.6K (−2.1%) vs. Q2 2022
- Total value
- $687.4M
- −$106.0M (−13.4%) vs. Q2 2022
- New holders
- 17
- 39 more added
- Sold out
- 10
- 29 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MRUS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 10 | $5.73M |
| Q3 2025 | 268 | $6.70B |
| Q2 2025 | 201 | $3.93B |
| Q1 2025 | 185 | $2.98B |
| Q4 2024 | 192 | $2.96B |
| Q3 2024 | 189 | $3.45B |
| Q2 2024 | 179 | $3.94B |
| Q1 2024 | 156 | $2.31B |
| Q4 2023 | 131 | $1.41B |
| Q3 2023 | 113 | $1.12B |
| Q2 2023 | 114 | $1.09B |
| Q1 2023 | 104 | $672.0M |
| Q4 2022 | 91 | $563.8M |
| Q3 2022 | 100 | $687.4M |
| Q2 2022 | 93 | $793.4M |
| Q1 2022 | 95 | $878.1M |
| Q4 2021 | 103 | $1.05B |
| Q3 2021 | 64 | $487.8M |
| Q2 2021 | 68 | $564.3M |
| Q1 2021 | 59 | $558.3M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Merus N.V.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −995,397−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −395,250−100.0% | Sold out |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −235,158−100.0% | Sold out |
| Kynam Capital Management, LP | 0 | $0 | 0.00% | −103,627−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −53,703−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −20,401−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −9,460−100.0% | Sold out |
| Fairfield, Bush & Co. | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −173−100.0% | Sold out |